Sherbrooke Park Advisers’s Globus Medical GMED Stock Holding History

Sherbrooke Park Advisers’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-15,684	Closed	-$926K	–	602
2025 Q2	$926K	Buy	+15,684	New	+$1.01M	0.4%	51
2025 Q1	–	Sell	-10,308	Closed	-$853K	–	734
2024 Q4	$853K	Buy	+10,308	New	+$813K	0.27%	81
2023 Q3	–	Sell	-5,400	Closed	-$322K	–	550
2023 Q2	$322K	Buy	5,400 +1,000	+23%	+$57K	0.17%	244
2023 Q1	$249K	Buy	4,400 +400	+10%	+$25.6K	0.38%	133
2022 Q4	$297K	Buy	+4,000	New	+$272K	0.22%	194

Other funds holding GMED

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

Sherbrooke Park Advisers's GMED Position: Q3 2025 in Review

Sherbrooke Park Advisers sold out of Globus Medical (GMED) in Q3 2025, closing a stake of 15,684 shares — an estimated $926K sold.

Sherbrooke Park Advisers first reported a position in GMED in Q4 2022 and held it in 5 quarters. The position peaked at $926K in Q2 2025. 490 funds tracked by Wall St. Rank hold GMED as of Q3 2025.

Sherbrooke Park Advisers reported no remaining Globus Medical position as of Q3 2025 after selling out during the quarter.
Sherbrooke Park Advisers sold 15,684 Globus Medical shares in Q3 2025, an estimated $926K.
Sherbrooke Park Advisers first reported a position in Globus Medical in Q4 2022 and held it in 5 quarters.
Sherbrooke Park Advisers's Globus Medical position peaked at $926K in Q2 2025.
490 funds tracked by Wall St. Rank held Globus Medical as of Q3 2025.

Based on Sherbrooke Park Advisers's 13F filing for Q3 2025, filed 14 Nov 2025.